Characterizing colorectal cancer (CRC) carriers of the recessive MUTYH founders (G396D/Y179C) and the low-penetrance APC founder APC-I1307K mutation.

Authors

null

Dong Kim

Fox Chase Cancer Center, Philadelphia, PA;

Dong Kim , Andrew Elliott , Phillip Walker , Sanjay Goel , Wafik S. El-Deiry , Emmanuel S. Antonarakis , Heinz-Josef Lenz , Joanne Xiu , Jeffrey Swensen , Matthew James Oberley , David Spetzler , Wolfgang Michael Korn , Michael J. Hall

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 210)

DOI

10.1200/JCO.2023.41.4_suppl.210

Abstract #

210

Poster Bd #

L12

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Analysis of HLA gene expression in patients with dMMR/MSI-H colorectal carcinoma resistant to immune checkpoint inhibitors.

Analysis of HLA gene expression in patients with dMMR/MSI-H colorectal carcinoma resistant to immune checkpoint inhibitors.

First Author: Heinz-Josef Lenz

First Author: Pooja Mittal

Poster

2023 ASCO Gastrointestinal Cancers Symposium

<em>SETD2</em> gene expression and the molecular landscape of colorectal cancer (CRC).

SETD2 gene expression and the molecular landscape of colorectal cancer (CRC).

First Author: Francesca Battaglin